$ARRT
Artisan Consumer Goods, Inc.

2022 Q2 Form 10-Q Financial Statement

#000147793222003184 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $3.330K $3.380K $5.590K
YoY Change 455.0% -62.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $750.00 $750.00 $750.00
YoY Change
% of Gross Profit
Operating Expenses $4.080K $4.127K $6.342K
YoY Change 591.53% -54.08% 5.44%
Operating Profit -$4.127K -$6.342K
YoY Change -54.08% 5.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$40.00 $150.00 -$2.686K
YoY Change -121.05% -101.18% -81.2%
Pretax Income -$12.34K -$3.980K -$9.030K
YoY Change -203.35% -81.68%
Income Tax
% Of Pretax Income
Net Earnings -$12.34K -$3.977K -$9.028K
YoY Change -203.35% -81.7% -55.53%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.805K -$904.50 -$2.052K
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares 4.400M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.56K $16.94K $20.05K
YoY Change 1406.67% 591.43%
Cash & Equivalents $13.56K $16.94K $20.05K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $8.224K
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables
Total Short-Term Assets $21.78K $16.94K $20.05K
YoY Change 2317.2% 591.43%
LONG-TERM ASSETS
Property, Plant & Equipment $6.125K
YoY Change
Goodwill
YoY Change
Intangibles $1.000K $1.000K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.125K $7.880K $8.625K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $21.78K $16.94K $20.05K
Total Long-Term Assets $7.125K $7.880K $8.625K
Total Assets $28.90K $24.82K $28.67K
YoY Change 3107.99% 913.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.69K $29.54K $29.51K
YoY Change 41.23% -35.53%
Accrued Expenses $48.29K $48.25K $48.40K
YoY Change 0.03% -0.43%
Deferred Revenue
YoY Change
Short-Term Debt $154.2K $154.2K $154.2K
YoY Change 50.46% 50.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $248.2K $232.0K $232.1K
YoY Change 35.53% 17.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $248.2K $232.0K $232.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $248.2K $232.0K $232.1K
YoY Change 35.53% 17.9%
SHAREHOLDERS EQUITY
Retained Earnings -$19.22M -$19.20M -$19.20M
YoY Change 0.2%
Common Stock $4.400K $4.400K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$219.3K -$207.2K -$203.5K
YoY Change
Total Liabilities & Shareholders Equity $28.90K $24.82K $28.67K
YoY Change 3107.99% 913.06%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$12.34K -$3.977K -$9.028K
YoY Change -203.35% -81.7% -55.53%
Depreciation, Depletion And Amortization $750.00 $750.00 $750.00
YoY Change
Cash From Operating Activities -$3.390K -$3.110K -$10.14K
YoY Change 118.71% -76.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.390K -3.110K -10.14K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -3.390K -3.110K -10.14K
YoY Change 118.71% 5.07%
FREE CASH FLOW
Cash From Operating Activities -$3.390K -$3.110K -$10.14K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$3.390K -$3.110K -$10.14K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
8987 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4127 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8987 USD
CY2022Q1 arrt Other Income Expense
OtherIncomeExpense
150 USD
CY2021Q1 arrt Other Income Expense
OtherIncomeExpense
-12746 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12746 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3977 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-21733 USD
CY2022Q1 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2021Q1 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022Q1 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
2968 USD
CY2022Q1 arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
164 USD
CY2021Q1 arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
531 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4127 USD
CY2021Q1 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-172987 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
385 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-21733 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-194335 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-173040 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-24695 USD
us-gaap Net Income Loss
NetIncomeLoss
3400 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-194335 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-203454 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
245 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3977 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-207186 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-182216 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1225 USD
us-gaap Net Income Loss
NetIncomeLoss
-26195 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-207186 USD
us-gaap Profit Loss
ProfitLoss
26195 USD
us-gaap Profit Loss
ProfitLoss
-3400 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2125 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1225 USD
arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
-21 shares
arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
603 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
367 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2812 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7362 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25678 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12963 USD
arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
-10000 USD
arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
51719 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51719 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16041 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2963 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5409 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16942 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2446 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
245 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
385 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1225 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-24695 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19203084 USD
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
750 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2125 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12746 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
154216 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
102497 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares

Files In Submission

Name View Source Status
0001477932-22-003184-index-headers.html Edgar Link pending
0001477932-22-003184-index.html Edgar Link pending
0001477932-22-003184.txt Edgar Link pending
0001477932-22-003184-xbrl.zip Edgar Link pending
arrt-20220331.xsd Edgar Link pending
arrt-20220331_cal.xml Edgar Link unprocessable
arrt-20220331_def.xml Edgar Link unprocessable
arrt-20220331_lab.xml Edgar Link unprocessable
arrt-20220331_pre.xml Edgar Link unprocessable
arrt_10q.htm Edgar Link pending
arrt_10q_htm.xml Edgar Link completed
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending